FRANKLIN BERGER - 18 Jun 2025 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role: Director
Signature: /s/ Marc Belsky, Attorney-in-Fact
Issuer symbol: KZR
Transactions as of: 18 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 23 Jun 2025, 17:00:08 UTC
Previous filing: 17 Jan 2025
Next filing: 24 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BERGER FRANKLIN M	Director	C/O KEZAR LIFE SCIENCES, INC., 4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO	/s/ Marc Belsky, Attorney-in-Fact	23 Jun 2025	0001273885

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KZR	Stock Option (right to buy)	Award	$0	+5,000		$0.000000	5,000	18 Jun 2025	Common Stock	5,000	$4.46	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-hundred percent (100%) of the shares subject to the option shall vest on 6/18/2026, subject to Reporting Person continuing to provide service through such date.